Earnings History Data for Evommune Inc. (EVMN) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Evommune Inc.
Evommune Inc. is a clinical-stage biotechnology company developing innovative therapies that target key drivers of chronic inflammatory diseases. Evommune Inc. is based in PALO ALTO, Calif.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11-12-2025 | AH | EVMN | Evommune Inc. | 537.00 | N/A | -6.58 | 0.00 | Evommune, Inc. GAAP EPS of -$8.07, revenue of $10M [12/11/2025 4:15 PM] |
19.69 | 0.08 (0.41%) |
19.69 | 0.0 (0.00%) |
16.70 - 24.03 | 262,745 | 110,000 | 1,813 | ||
| Google finance search Google investor relations search SeekingAlpha Zacks Finviz CNBC Yahoo Finance MarketWatch Nasdaq quote StockTwits TradingView AlphaQuery InvestorPlace ChartMill | ||||||||||||||||||